American Academy of Neurology: 2014 Annual Meeting

Philadelphia, Pennsylvania, U.S.A.

26 April – 03 May 2014


Back to the Top

Tau imaging of patients with different kinds of dementia and a peptide microarray that detects antibody patterns in Alzheimer's disease blood samples were among the highlights of the American Academy of Neurology annual meeting, held April 26-May 3 in Philadelphia. Alzforum coverage includes the latest on the newly approved amyloid tracer florbetaben, and a snapshot of this year’s Potamkin Prize winner.

Mesulam Awarded Potamkin Prize

Marek-Marsel Mesulam received the prestigious award for his research on primary progressive aphasia, a language disorder that can affect people with Alzheimer’s or frontotemporal dementia.